Industry Insights
-
Patient Trust In Pharma Is Low; Here's How To Rebuild It
2/2/2026
CISCRP's Annick de Bruin and Shalome Sine provide strategies for building patient trust based on the findings from their Perceptions & Insights Study.
-
The Power Of A Collaboration Platform
1/30/2026
Using a recent Phase III Endocrinology trial as a primary case study, this article illustrates the qualitative shift from administrative burden to strategic oversight.
-
How To Streamline The Complexity Of Clinical Trials
1/30/2026
Streamlining intricate end-to-end processes ensures that data moves with speed and security, converting the current landscape of logistical bottlenecks into a transparent, high-efficiency engine.
-
The U.S. Trial Advantage Is Eroding
1/30/2026
Once the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, economic, and workforce pressures domestically and rapid growth abroad.
-
Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
1/29/2026
Learn why the next frontier in AI governance will involve real-time surveillance of algorithmic performance across institutions with guidance from Akshaya Bhagavathula and Michelle A. Williams.
-
Want To Optimize Clinical Project Team Performance? Try This Formal 'Lessons Learned' Process
1/28/2026
Learn how a formal "lessons learned" process can help teams work collaboratively with open, honest, and timely communication to reach thoughtful decisions that lead to on-time, on-budget, and inspection-ready trials.
-
4 Factors Changing The Way CRAs Monitor Trials
1/28/2026
The way CRAs monitor is about to change. Regeneron's Patrick Floody discusses these four factors that will influence it.
-
How Can AI Change Computerized System Validation?
1/27/2026
Learn how AI technologies are changing the computer system validation (CSV) landscape and what you need to understand about this transformation.
-
Too Little Info, Too Much Time Wasted: Feasibility Challenges For Sites
1/27/2026
Incomplete protocols, lengthy sponsor decision timelines, and uncompensated work plague clinical research sites. Learn why these issues exist and how to address them alongside experts from SCRS and Tufts CSDD.
-
Will New AI Health Assistants Suggest Clinical Trials To Inquiring Patients?
1/27/2026
New AI health assistants are now doing even more to help patients make sense of symptoms, diagnoses, and treatment options. What does that mean for the discoverability of clinical trials?